Wilson Sonsini Goodrich & Rosati and Fenwick & West LLP advised Day One Biopharmaceuticals on the deal. San Francisco-based Day One Biopharmaceuticals, a Phase 2 biotech...
Day One Biopharmaceuticals’ IPO
Day One Biopharmaceuticals’ $130 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Day One Biopharmaceuticals on the deal. Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on accelerating new, promising targeted therapies...